DOMINICI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 27.686
EU - Europa 13.673
AS - Asia 5.579
SA - Sud America 130
AF - Africa 58
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 23
Totale 47.207
Nazione #
US - Stati Uniti d'America 27.467
IT - Italia 4.202
GB - Regno Unito 3.682
SG - Singapore 1.680
CN - Cina 1.536
SE - Svezia 1.491
DE - Germania 1.261
HK - Hong Kong 962
UA - Ucraina 496
IE - Irlanda 490
TR - Turchia 475
FI - Finlandia 466
RU - Federazione Russa 372
ID - Indonesia 337
BG - Bulgaria 271
FR - Francia 263
CA - Canada 195
IN - India 145
BE - Belgio 134
JP - Giappone 119
NL - Olanda 110
BR - Brasile 90
VN - Vietnam 75
LT - Lituania 60
RO - Romania 60
CZ - Repubblica Ceca 57
AU - Australia 56
ES - Italia 48
IR - Iran 48
MY - Malesia 39
CH - Svizzera 37
PL - Polonia 29
TW - Taiwan 29
NO - Norvegia 27
KR - Corea 26
PK - Pakistan 25
AT - Austria 22
AL - Albania 21
CL - Cile 16
EU - Europa 16
EG - Egitto 14
IL - Israele 14
PT - Portogallo 13
PH - Filippine 11
BZ - Belize 10
DK - Danimarca 9
MX - Messico 9
MA - Marocco 8
AR - Argentina 7
GR - Grecia 7
RS - Serbia 7
ZA - Sudafrica 7
A2 - ???statistics.table.value.countryCode.A2??? 6
HR - Croazia 6
KE - Kenya 6
SA - Arabia Saudita 6
DZ - Algeria 5
IQ - Iraq 5
MT - Malta 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CO - Colombia 4
CR - Costa Rica 4
HU - Ungheria 4
KZ - Kazakistan 4
MK - Macedonia 4
OM - Oman 4
PE - Perù 4
SI - Slovenia 4
BD - Bangladesh 3
EE - Estonia 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
NG - Nigeria 3
UG - Uganda 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DJ - Gibuti 2
EC - Ecuador 2
ET - Etiopia 2
GH - Ghana 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AN - Antille olandesi 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
GA - Gabon 1
Totale 47.194
Città #
Fairfield 3.780
Santa Clara 3.607
Southend 2.741
Chandler 2.281
Woodbridge 1.976
Ashburn 1.946
Houston 1.530
Singapore 1.340
Seattle 1.334
Cambridge 1.172
Wilmington 1.146
Ann Arbor 1.112
Nyköping 979
Jacksonville 963
Hong Kong 930
Dearborn 859
Modena 535
Dublin 461
San Diego 417
Beijing 396
New York 352
Jakarta 329
Princeton 306
Helsinki 304
Izmir 303
Bologna 298
Milan 295
Munich 288
Sofia 271
Eugene 200
London 159
Shanghai 147
Moscow 145
Redwood City 130
Parma 128
Rome 125
Des Moines 120
Falls Church 119
Bremen 114
Brussels 113
Mcallen 109
Fremont 107
Boardman 106
Montréal 103
Reggio Emilia 95
Frankfurt am Main 77
Tokyo 71
Dong Ket 60
Phoenix 59
Grafing 56
Norwalk 56
Guangzhou 55
Brno 47
San Giuliano Milanese 46
Los Angeles 40
Toronto 40
Amsterdam 37
Chicago 37
San Mateo 36
Verona 36
Nanjing 35
Enfield 33
Padova 32
Ravenna 32
Dallas 31
Florence 30
Hefei 30
Chiswick 27
Hounslow 27
Kilburn 27
Naples 27
Palermo 26
Ottawa 25
Paris 25
Vicenza 25
Bari 24
Napoli 24
Timisoara 23
Casalecchio Di Reno 22
Dongguan 22
Genoa 22
Kunming 21
Turin 20
Mountain View 18
Pavia 18
Rimini 18
Roncoferraro 18
Nuremberg 16
Bergen 15
Ferrara 15
Kuala Lumpur 15
Lahore 15
Philadelphia 15
Reggio Nell'emilia 15
San Jose 15
Zhengzhou 15
Augusta 14
Jinan 14
Leawood 14
Piacenza 14
Totale 35.898
Nome #
Dynamic cultivation of mesenchymal stem cell aggregates 598
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 377
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 326
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 322
GD2 expression in breast cancer. 314
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 312
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 298
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 297
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 297
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 294
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 287
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 283
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 281
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 280
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 278
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 276
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 275
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 274
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 273
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 272
A novel function for amniotic fluid: original or authentic? 256
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 256
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 256
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 255
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 252
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 247
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 247
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 247
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 240
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 238
Tumor Stroma Manipulation By MSC 236
An alternative approach to investigate biofilm in medical devices: A feasibility study 230
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 227
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 227
Identification of a murine CD45-F4/80lo HSC-derived marrow endosteal cell associated with donor stem cell engraftment 226
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 225
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 224
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 223
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 221
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 221
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 221
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 219
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 217
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 217
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 216
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 216
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 212
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 211
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 210
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 208
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 206
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 206
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 205
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 204
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 203
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 202
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 200
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 198
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 196
Bone marrow mesenchymal cells: biological properties and clinical applications. 195
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 195
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 194
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 194
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 193
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 193
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 192
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities 192
Cell therapies for pancreatic beta-cell replenishment. 191
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 191
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 190
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 188
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 186
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 184
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 184
GD2 CAR T cells against human glioblastoma 184
The Survey on Cellular and Engineered Tissue Therapies in Europe in 2013 183
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 183
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 183
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 183
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 183
Part 1: Defining unproven cellular therapies 182
Mesenchymal stromal cells for cutaneous wound healing in a rabbit model: pre-clinical study applicable in the pediatric surgical setting 182
The phenotypes of microglia and macrophages during epileptogenesis 181
Detection of microparticles from human red blood cells by multiparametric flow cytometry 180
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 179
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 178
Mesenchymal stromal/stem cells markers in the human bone marrow 177
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 177
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 175
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning 174
Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, May 2, 2018 174
Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms 173
Part 5: Unproven cell therapies and the commercialization of cell-based products 173
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation 173
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 172
Trophoblast stem cells rescue placental defect in SOCS3-deficient mice 172
Response to Nature commentary “Clear up this stem-cell mess” 172
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 172
Device for cell culture 171
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 171
Totale 22.404
Categoria #
all - tutte 224.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.572


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.587 0 0 0 0 0 0 1.244 697 653 282 436 275
2020/20217.895 628 377 655 798 1.004 638 478 734 469 890 792 432
2021/20226.659 365 738 581 348 284 474 400 410 653 525 1.072 809
2022/20237.308 824 784 544 663 742 907 191 654 1.160 136 404 299
2023/20245.124 257 309 365 495 823 502 513 600 154 196 287 623
2024/20257.929 497 226 488 1.146 2.697 2.488 387 0 0 0 0 0
Totale 47.903